Parasitology Research

, 103:771 | Cite as

In vitro infectivity of species of Leishmania (Viannia) responsible for American cutaneous leishmaniasis

  • Marliane Batista Campos
  • Cláudia Maria De Castro Gomes
  • Adelson Alcimar Almeida de Souza
  • Ralph Lainson
  • Carlos Eduardo Pereira Corbett
  • Fernando Tobias SilveiraEmail author
Original Paper


There is little available information regarding the infectivity of New World Leishmania species, particularly those from the Amazonian Brazil, where there are six species of the subgenus Viannia causing American cutaneous leishmaniasis (ACL). The aim of this study was to compare, in vitro, the potential infectivity of the following Leishmania (Viannia) spp.: L. (V.) braziliensis from localized cutaneous leishmaniasis (LCL) and mucocutaneous leishmaniasis (MCL) patients, L. (V.) guyanensis, L. (V.) shawi, L. (V.) lainsoni and L. (V.) naiffi from LCL patients only, in cultured BALB/c mice peritoneal macrophage, as well as the production of NO by the infected cells. The infectivity of parasites was expressed by the infection index and, the nitric oxide (NO) production in the macrophage culture supernatant was measured by the Griess method. It was found that L. (V.) braziliensis from MCL, the more severe form of disease, showed the highest (p ≤ 0.05) infection index (397), as well as the lowest NO production (2.15 μM) compared with those of other species. In contrast, L. (V.) naiffi which is less pathogenic for the human showed the lowest infection index (301) and the highest NO production (4.11 μM). These results demonstrated a negative correlation between the infectivity and the ability of these parasites to escape from the microbicidal activity of the host cell.


Nitric Oxide Leishmaniasis Cutaneous Leishmaniasis Infected Macrophage Mouse Peritoneal Macrophage 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



This work received financial support from the Instituto Evandro Chagas (Secretaria de Vigilância em Saúde, Ministério da Saúde, Brazil), Instituto de Medicina Tropical (Universidade Federal do Pará, Brazil) Wellcome Trust (London) and Laboratório de Investigação Médica (LIM)-50 (Hospital de Clínicas (HC)-Faculdade de Medicina (FM)-Universidade de São Paulo (USP), Brazil).


  1. Arevalo J, Ramirez L, Adaui V, Zimic M, Tulliano G, Miranda-Verástegui C, Lazo M, Loayza-Muro R, De Doncker S, Maurer A, Chappuis F, Dujardin JC, Llanos-Cuentas A (2007) Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis. J Infect Dis 195:1846–1851PubMedCrossRefGoogle Scholar
  2. Balestieri FM, Queiroz AR, Scavone C, Costa VM, Barral-Neto M, Ahamsohn I (2002) Leishmania (L.) amazonensis-induced inhibition of nitric oxide synthesis in host macrophages. Mic Inf 4:23–29CrossRefGoogle Scholar
  3. Castellucci L, Menezes E, Oliveira J, Magalhães A, Guimarães LH, Lessa M, Ribeiro S, Reale J, Noronha EF, Wilson ME, Duggal P, Beaty TH, Jerônimo S, Jamieson SE, Bales A, Blackwell JM, de Jesus AR, Carvalho EM (2007) IL6-174 G/C promoter polymorphism influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil. J Infect Dis 194:519–527CrossRefGoogle Scholar
  4. Delorenzi JC, Attias M, Gattass CR, Andrade M, Rezende C, Pinto AC, Henriques AT, Bou-habib DC, Saraiva BEM (2001) Antileishmanial activity of an indole alkaloid from Peschiera australis. Antimic Ag Chemoth 45:1349–1354CrossRefGoogle Scholar
  5. Giudice A, Camada I, Leopoldo TG, Pereira JMB, Riley LW, Wilson ME, Ho JL, De Jesus AR, Carvalho EM, Almeida R (2007) Resistance of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis to nitric oxide correlates with disease severity in Tegumentary Leishmaniasis. B M C Inf Dis 7:1–12Google Scholar
  6. Gomes CMC, Silveira FT, Laurenti MD, Costa JML, Tomokane TY, Souza MGT, Corbett CEP (2003) Biological behavior of Leishmania (Leishmania) amazonensis isolated from different clinical forms of American tegumentar leishmaniasis in Balb/c mice. Rev Inst Med Trop São Paulo 45(Supl. 13):65Google Scholar
  7. Green SG, Meltzer NS, Hibbs JB, Nancy CA (1990) Activated macrophage destroys intracellular Leishmania major amastigotes by an l-arginine dependent killing mechanism. J Immunol 144:278–283PubMedGoogle Scholar
  8. Grimm F, Brun C, Jenni L (1991) Promastigote infectivity in Leishmania infantum. Parasitol Res 77:185–191PubMedCrossRefGoogle Scholar
  9. Hay Q, Popov V, Soong L (2001) Leishmania amazonensis-dendritic cell interactions in vitro and the priming of parasite-specific CD4+ T cells in vivo. J Immunol 167:4534–4542Google Scholar
  10. Lainson R, Shaw JJ (1987) Evolution, classification and geographical distribution. In: Peters W, Killick-Kendrick R (eds) The Leishmaniases in biology and medicine, vol 1. Academic Press, London, pp 1–120Google Scholar
  11. Lainson R, Shaw JJ, Silveira FT, Braga RR, Ishikawa EAY (1990) Cutaneous leishmaniasis of man due to Leishmania (Viannia) naiffi Lainson & Shaw, 1989. Ann Parasitol Hum Comp 65:282–284PubMedGoogle Scholar
  12. Liew FY, O’Donnell CA (1993) Immunology of Leishmaniasis. Ad Parasitol 32:161–259CrossRefGoogle Scholar
  13. Lucas CM, Franke ED, Cachay MI, Tejada A, Carrizales D, Kreutzer RD (1994) Leishmania (Viannia) lainsoni: first isolation in Peru. Am J Trop Med Hyg 51:533–537PubMedGoogle Scholar
  14. Maia C, Rolão N, Nunes M, Gonçalves L, Campino, L (2007) Infectivity of five different types of macrophages by Leishmania infantum. Acta Tropica 103:150–155PubMedCrossRefGoogle Scholar
  15. Rey JA, Travi BL, Valencia AZ, Saravia NG (1990) Infectivity of subspecies of the Leishmania braziliensis complex in vivo and in vitro. Am J Trop Med Hyg 43:623–631PubMedGoogle Scholar
  16. Sacks DL, Perkins PV (1984) Identification of an infective stage of Leishmania promastigotes. Science 223:1417–1419PubMedCrossRefGoogle Scholar
  17. Sacks DL, Perkins PV (1985) Development of infective stage of Leishmania promastigotes within phlebotomine sandflies. Am J Med Hyg 34:456–459Google Scholar
  18. Silveira FT, Moraes MAP, Lainson R, Shaw JJ (1990) Experimental cutaneous leishmaniasis. III—histopathological aspects of the developmental behavior of the cutaneous lesions induced in the Cebus apella monkey (Primates: Cebidae) by Leishmania (Viannia) lainsoni, L. (V.) braziliensis e L. (Leishmania) amazonensis. Rev Inst Med Trop São Paulo 32:387–394PubMedGoogle Scholar
  19. Silveira FT, Shaw JJ, Lainson R (1999) Experimental cutaneous leishmaniasis in the Cebus apella monkey (Primates: Cebidae): evaluation of the monkey susceptibility to infection by Leishmania (Viannia) shawi and L. (V) naiffi. Rev Soc Bras Med Trop 32(Sup I):259Google Scholar
  20. Silveira FT, Ishikawa EAI, De Souza AAA, Lainson R (2002) An outbreak of cutaneous leishmaniasis among soldiers in Belém, Pará State, Brazil caused by Leishmania (Viannia) lindenbergi n. sp., a new leishmanial parasite of man in the Amazon region. Parasite 9:43–50PubMedGoogle Scholar
  21. Silveira FT, Lainson R, Corbett CEP (2004) Clinical and immunopathological spectrum of American cutaneous leishmaniasis with special reference to the disease in Amazonian Brazil. Mem Inst Oswaldo Cruz 99:239–251PubMedCrossRefGoogle Scholar
  22. Sisto M, Brandonisio O, Panaro MA, Acquafredda A, Leogrande D, Fasanella A, Trota T, Fumarola L, Mitolo V (2000) Inducible nitric oxide synthase expression (iNOS) in Leishmania-infected dog macrophage. Comp Immunol Mic Inf Dis 24:247–254CrossRefGoogle Scholar
  23. Tojal da Silva AC, Cupolillo E, Volpini AC, Almeida R, Romero GA (2006) Species diversity causing human cutaneous leishmaniasis in Rio Branco, state of Acre, Brazil. Trop Med Int Health 11:1388–1398PubMedCrossRefGoogle Scholar
  24. Walton BC, Shaw JJ, Lainson R (1977) Observations on the in vitro cultivation of Leishmania braziliensis. J Parasitol 63:1118–1119PubMedCrossRefGoogle Scholar
  25. Zakai HA, Chance ML, Bates PA (1992) In vitro stimulation of metacyclogenesis in Leishmania (Viannia) braziliensis, L. (Leishmania) donovani, L. (L.) major and L. (L.) mexicana. Parasitol 116:305–309CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Marliane Batista Campos
    • 1
  • Cláudia Maria De Castro Gomes
    • 2
  • Adelson Alcimar Almeida de Souza
    • 1
  • Ralph Lainson
    • 1
  • Carlos Eduardo Pereira Corbett
    • 2
  • Fernando Tobias Silveira
    • 1
    • 3
    • 4
    Email author
  1. 1.Evandro Chagas Institute (Surveillance Secretary of Health, Ministry of Health)BelémBrazil
  2. 2.Pathology DepartmentMedical School of São Paulo UniversitySão PauloBrazil
  3. 3.Tropical Medicine InstitutePará Federal UniversityBelémBrazil
  4. 4.Departamento de ParasitologiaInstituto Evandro Chagas—(SVS, MS)BelémBrazil

Personalised recommendations